FameWave Acquisition Marks Kitov’s Transition Into Oncology
Kitov Pharma recently contracted an arrangement to acquire FameWave Ltd. for a share exchange transaction. FameWave shareholders will receive $10M worth of newly issued KTOV ADSs (U.S. Listing)
China’s Regulatory Authority [NMPA] Approves Oramed’s Oral Insulin Capsules IND Application
The Chinese partner of Oramed Pharmaceuticals Inc., Hefei Tianhui Incubator of Technologies Co., Ltd, has reached the significant regulatory milestone of approval of an investigational new drug application
Yarok Microbio combines Chemicals with AI to identify Dangerous Bacteria in Produce
Israeli startup Yarok Microbio says it has developed a way to identify life-threatening bacteria in as little as under an hour, before the food products they could
Insulin Replacement Company Betalin Therapeutics Raises $2.5m
Israeli diabetes treatment developer Betalin Therapeutics has raised $2.5 million from leading venture capital funds and private investors for its revolutionary treatment, which would replace insulin therapy.
Intec Pharma’s Pharmacokinetic Study of Accordion Pill™ Carbidopa/Levodopa 50/500 mg Dosed 3x Daily Report Positive Results
Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec”)presented the preliminary results from a pharmacokinetic (PK) study comparing the Company’s Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) 50/500mg dosed three times daily
Clinical Research on Medical Cannabis Inhalers by Rafa & Panaxia Pharmaceutical Industries to offer immediate Pain Relief to Cancer Patients
As a means of providing immediate pain relief for cancer patients, scientists are carrying out clinical research with Rafa and Panaxia, two Israeli-based pharmaceutical companies, on delivering
Hadasit, IBM set up digital health accelerator at Hadassah Ein Kerem, first startups already running
Hadasit, the Hadassah Medical Organization’s technology transfer company, has launched Israel’s first biotechnology hub within a medical center. Hadassah Accelerator is powered by IBM Alpha
BIONDVAX Edges Closer to Elusive Universal Flu Vaccine
Jerusalem-based BiondVax Pharmaceuticals is edging closer to an unprecedented universal, multi-season and multi-strain flu vaccine capable of protecting all of us from current and future,
Cancer Treatment Company HIL to Set Up $5 Million Jerusalem Manufacture Center
Jerusalem-based cancer treatment company HIL Applied Medical Ltd. has signed an agreement to lease a 700 square-meter space from The Hebrew University of Jerusalem to
